Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioparhom is a French medical device company focused on bioimpedance-based body composition analysis for healthcare, nutrition, sports, research, and veterinary use. The company historically developed and commercialized the Z-Métrix professional medical impedancemeter and related bioimpedance tools, with applications including nutritional status assessment, hydration analysis, and physiologic monitoring. Its technology has been positioned as clinically validated and used by medical, paramedical, and sports professionals in France. In September 2025, Bioparhom was acquired by COSMED France and now operates as the bioimpedance unit within COSMED France, while its historical products and expertise are being integrated into the broader COSMED diagnostics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioparhom.